 |
|
Opportunities for Cost-effective Prevention of Late-Life Depression
An Epidemiological Approach
Filip Smit, MSc;
Agnieska Ederveen, MD;
Pim Cuijpers, PhD;
Dorly Deeg, PhD;
Aartjan Beekman, MD, PhD
Arch Gen Psychiatry. 2006;63:290-296.
Context Clinically relevant late-life depression has a prevalence of 16% and is associated with substantial societal costs through its disease burden and unfavorable prognosis. From the public health perspective, depression prevention may be an attractive, if not imperative, means to generate health gains and reduce future costs.
Objective To target high-risk groups for depression prevention such that maximum health gains are generated against the lowest cost.
Design Population-based cohort study over 3 years.
Setting General population in the Netherlands.
Participants Twenty-two hundred community residents aged 55 to 85 years. Of these, 1925 were not depressed at baseline.
Main Outcome Measure The onset of clinically relevant depression was measured with the Center for Epidemiological Studies Depression Scale. For each of the risk factors (and their combinations), we calculated indices of potential health gain and the effort (costs) required to generate those health gains.
Results One in every 5 cases of clinically relevant late-life depression is a new case. Consequently, depression prevention has to play a key role in reducing the influx of new cases. This is best done by directing prevention efforts toward elderly people who have depressive symptoms, experience functional impairment, and have a small social network, in particular women, as well as people who have attained only a low educational level or who suffer from chronic diseases.
Conclusions Directing prevention efforts toward selected high-risk groups could help reduce the incidence of depression and is likely to be more cost-effective than alternative approaches. This article further shows that we have the methodology at our disposal to conduct ante hoc cost-benefit analysis in preventive psychiatry. This helps set a rational research and development agenda before testing the cost-effectiveness of interventions in time-consuming and expensive trials.
Author Affiliations: Trimbos Institute (Netherlands Institute of Mental Health and Addiction), Utrecht (Mr Smit and Drs Cuijpers and Beekman), and Departments of Psychiatry (Drs Ederveen, Deeg, and Beekman) and Clinical Psychology (Dr Cuijpers), Vrije Universiteit Amsterdam, the Netherlands.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Preventing Depression in Old Age: It's Time
Reynolds
AJGP 2008;16:433-434.
FULL TEXT
Brief Interventions to Prevent Depression in Older Subjects: A Systematic Review of Feasibility and Effectiveness
Cole
AJGP 2008;16:435-443.
ABSTRACT
| FULL TEXT
An Epidemiological Approach to Depression Prevention in Old Age
Smits et al.
AJGP 2008;16:444-453.
ABSTRACT
| FULL TEXT
Preventing Depression in Later Life: Translation From Concept to Experimental Design and Implementation
Sriwattanakomen et al.
AJGP 2008;16:460-468.
ABSTRACT
| FULL TEXT
Outcomes and Predictors of Late-Life Depression Trajectories in Older Primary Care Patients
Cui et al.
AJGP 2008;16:406-415.
ABSTRACT
| FULL TEXT
Preventing Depression in Medical Illness: A New Lead?
Reynolds et al.
Arch Gen Psychiatry 2007;64:884-885.
FULL TEXT
Preventing Depression in Age-Related Macular Degeneration
Rovner et al.
Arch Gen Psychiatry 2007;64:886-892.
ABSTRACT
| FULL TEXT
Target groups for the prevention of late - life anxiety
Smit et al.
Br. J. Psychiatry 2007;190:428-434.
ABSTRACT
| FULL TEXT
The Role of Perceived Control in Explaining Depressive Symptoms Associated With Driving Cessation in a Longitudinal Study
Windsor et al.
Gerontologist 2007;47:215-223.
ABSTRACT
| FULL TEXT
Prevention of Late-Life Depression in Primary Care: Do We Know Where to Begin?
Schoevers et al.
Am. J. Psychiatry 2006;163:1611-1621.
ABSTRACT
| FULL TEXT
Preventing Late-Life Depression
JWatch Women's Health 2006;2006:5-5.
FULL TEXT
|
